Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti-tumor activity in small cell carcinoma of the ovary, hypercalcemic type
Wang, Yemin, Chen, Shary Yuting, Colborne, Shane, Lambert, Galen, Shin, Chae Young, Dos Santos, Nancy, Orlando, Krystal A, Lang, Jessica D, Hendricks, William P.D., Bally, Marcel B., Karnezis, AnthonyLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-18-0348
Date:
September, 2018
File:
PDF, 5.37 MB
english, 2018